|[December 20, 2012]
ProNerve Announces the Acquisition of PhysIOM
CHICAGO --(Business Wire)--
Waud Capital Partners ("WCP") announced today that its portfolio
company, ProNerve (the "Company"), has acquired PhysIOM Group, LLC
("PhysIOM"), one of the largest providers of intraoperative
neuromonitoring ("IONM") services in the western and southeastern United
States. Headquartered in Colorado, PhysIOM serves over 290 hospital
clients across 33 states. PhysIOM represents ProNerve's third
acquisition in 2012 and establishes the Company as a national provider
of IONM services and the market leading provider of IONM services in the
western United States.
"Having a stated objective of building the leading provider of IONM
services in the western United States, we are thrilled to complete this
business combination," said David Neighbours, Partner at Waud Capital
Partners. WCP first invested in ProNerve in February 2012 and has also
completed acquisitions for ProNerve in Washington and Arizona.
"Individually, both companies are well respected in our field, but
combined we have a stronger platform from which to serve our customers,"
said Luke Johnson, Chief Executive Officer of ProNerve. "I look forward
to working with PhysIOM's management team as I believe their strengths
o be complementary to our organization."
"We are eager to begin the process of joining forces with ProNerve,"
said former PhysIOM Chief Executive Officer Rick Flores, who will become
President of ProNerve. "PhysIOM's employees, clinicians and clients have
all welcomed the news of this merger."
ProNerve is one of the leading providers of intraoperative
neuromonitoring services in the United States. IONM involves the use of
a variety of electro-physiological monitoring procedures during surgery
to allow for early warning and avoidance of injury to nervous systems
structures. ProNerve's IONM services include onsite technical support
provided by trained technologists in the operating room, combined with
real-time professional oversight delivered remotely by the Company's
team of clinicians. ProNerve's customers include health systems, acute
care hospitals, specialty hospitals, ambulatory surgery centers,
surgeons and physician groups.
For more information on ProNerve, visit www.pronerve.com.
About Waud Capital Partners
Waud Capital Partners (WCP) is a private equity investment firm founded
in 1993 that partners with exceptional management teams to invest in
middle-market growth equity investments, buyouts, industry
consolidations and recapitalizations. The firm seeks to invest $20
million to $100 million in private companies in the following four
areas: healthcare services, business, consumer and government services,
specialty distribution and value-added industrial. Typically, the
companies in which WCP invests have enterprise values between $30
million and $300 million. The firm has completed more than 100
acquisitions since its founding and currently has approximately $1
billion of capital under management.
For additional information on WCP, visit www.waudcapital.com.
[ Back To TMCnet.com's Homepage ]